NF-κB-mediated chemokine secretion bridges tumor cells and cells in the TME, and CXCR2 ligands (CXCL2 and CXCL3) enhance MDSC chemotaxis in advanced PCa9,16,18. This evidence concerns the gene CXCL2 and neoplasm.